Literature DB >> 1373314

Chromosomal abnormalities in skin following total body or total lymphoid irradiation.

C M Rubin1, M E Nesbit, T H Kim, J H Kersey, D C Arthur.   

Abstract

Patients undergoing bone marrow transplantation often receive total body or total lymphoid irradiation as part of the conditioning regimen prior to marrow infusion. The cytogenetic effects of this therapy on skin fibroblasts were studied. Fibroblast cultures from eight skin biopsies were harvested in early passages for G-banded chromosome analysis. Four biopsies were from three patients who had high-dose cyclophosphamide and total body radiotherapy; one was from within and one was from outside the radiation field of a patient who had high-dose cyclophosphamide and lymphoid radiotherapy, one was from a patient who had combination chemotherapy alone, and one was from a normal control. No abnormal mitoses were found in the control or the patient who had chemotherapy alone, and only two of 30 mitoses from skin outside the lymphoid radiotherapy field were abnormal. However, most cells (49-88%) from five biopsies within radiotherapy fields were abnormal. Typically, abnormal karyotypes were pseudodiploid and contained multiple balanced rearrangements, of which reciprocal translocations were most common. The data indicate that the radiotherapy used for bone marrow transplantation induces extensive, sustained chromosome abnormalities in vivo in skin fibroblasts.

Entities:  

Mesh:

Year:  1992        PMID: 1373314     DOI: 10.1002/gcc.2870040207

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  2 in total

1.  Therapy-related chromosomal changes and cytogenetic heterogeneity in human gliomas.

Authors:  Y S Li; D A Ramsay; D R Macdonald; R F Del Maestro
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation.

Authors:  G Massenkeil; P Zschieschang; G Thiel; P G Hemmati; V Budach; B Dörken; J Pross; R Arnold
Journal:  Radiat Oncol       Date:  2015-12-30       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.